Key Record Dates
| ClinicalTrials.gov Identifier: | NCT06099782 |
|---|---|
| Brief Title: | A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Hyaluronidase (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11) |
| First Submitted : | October 19, 2023 |
| First Submitted that Met QC Criteria : | October 19, 2023 |
| First Posted : | October 25, 2023 |
| Last Update Submitted that Met QC Criteria : | May 9, 2024 |
| Last Update Posted : | May 10, 2024 |